Do not use Scintimun:
- if you are allergic (hypersensitive) to besilesomab, to antibody from mouse origin or any other antibodies, to any of the other ingredients of Scintimun (see section 6) or to sodium pertechnetate ( 99mTc) solution.
- if you have a positive response to a test detecting human anti-mouse antibodies (HAMA test). Ask your doctor if you are not sure.
- if you are pregnant.
Take special care with Scintimun:
If any of these conditions are applicable to you, you should inform your doctor:
- if you had previously been administered Scintimun, because you should only be administered Scintimun once in your lifetime. If you are not sure if you have been given this before, please let your doctor know.
- if you previously had a scintigraphy with technetium in the last 2 days.
- if you have a tumoral pathology involving a secretion of carcino embryonic antigen (CEA) which could interfere with this investigation.
- if you have any blood disease.
The use of Scintimun involves the administration of a small amount of radioactivity. Because technetium( 99m Tc)-besilomab is administered by trained personnel, there are no precautions which are your responsibility. Because there are strict laws covering the handling, the use and disposal
of radioactivity, technetium( 99mTc)-besilomab is always used in a hospital or a similar setting. It is always handled by trained and qualified people.
In order to obtain images of best quality and to reduce the radiation exposure of your bladder, you should drink sufficient amounts and empty your bladder prior to and after the scintigraphic examination.
Because you could emit radiation especially harmful to young children during the first 12 hours after the injection, you may be told to avoid close contact with young children during this period of time.
This product is not recommended for use in patient below 18 years of age.
Scintimun should not be used for the diagnosis of diabetic foot infection.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any medicines, including medicines obtained without a prescription.
Medicines reducing inflammation and medicines affecting the production of your blood cells (such as corticosteroids or antibiotics) may affect the results of your examination.
You must not be given Scintimun if you are pregnant.
Ask your doctor or pharmacist for advice before taking any medicine.
You must tell your doctor if you have missed a period or if there is any chance you may be pregnant. Investigations in nuclear medicine may involve a risk to the unborn.
If you are breast feeding you may be told to stop breast-feeding for 3 days after your injection and the expressed milk should be discarded. If you wish you can express and store your breast milk before your injection. This will protect your child from the radiation that may be present in your breast milk. However you may be told to avoid close contact with your child during the first 12 hours after the injection.
Important information about some of the ingredients of Scintimun:
If you have an intolerance to some sugars (for example fructose, sorbitol), tell your doctor before you are given Scintimun.